🔎 Trials Near Me

Dachaigh › Galar Depressive Mòr › Pennsylvania › Philadelphia

Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Philadelphia, PA

Tha 23 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

A’ fastadhÌre 3
  • Adams Clinical Philadelphia, Philadelphia
  • Flourish Research Philadelphia, Philadelphia
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06793397

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

A’ fastadhÌre 3
  • Adams Clinical Philadelphia, Philadelphia
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

A’ fastadhÌre 3
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07412756

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

A’ fastadhÌre 3
  • Adams Clinical Philadelphia, Philadelphia
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300

Precision Depression Adalimumab Trial

A’ fastadhÌre 2
  • University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07845604

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

A’ fastadhÌre 3
  • University of Pennsylvania - Perelman School of Medicine, Philadelphia
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

A’ fastadhÌre 3
  • University of Pennsylvania, Philadelphia
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06559306

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

A’ fastadhÌre 1 tràth
  • University of Pennsylvania, Philadelphia
Aoisean 25 gu 65 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06788249

Decoding and Modulating Affective Brain States

A’ fastadhA’ toirt iomradh air pàigheadh do chom-pàirtichean
  • University of Pennsylvania, Philadelphia
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT05437705

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

A’ fastadhÌre 2
  • Draig Clinical Site, Media · 12 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

A’ fastadh
  • Pennsylvania Hospital, Philadelphia
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

A’ fastadhÌre 2
  • Draig Clinical Site, Media · 12 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07300969

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

A’ fastadhÌre 3
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07226232

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06963021

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

A’ fastadhÌre 3
  • Adams Clinical - Philadelphia, Philadelphia
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06775379

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A’ fastadhÌre 2
  • Adams Clinical, Philadelphia
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07196501

Triage Survey for Psychiatry Research Eligibility

A’ fastadhSgrùdadh amharc
  • Adams Clinical, Philadelphia, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

A’ fastadhÌre 2
  • University of Pennsylvania, Philadelphia
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830

Taking Action for College Students

A’ fastadh
  • Temple University, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Dùbh 2025 · NCT06700902

Neurofeedback to Treat Depression - 2

A’ fastadh
  • Center for Neuromodulation in Depression and Stress, Philadelphia
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 4 Dùbh 2025 · NCT07159061

Study of ALTO-300 in MDD

A’ fastadhÌre 2
  • Site 350, Media · 12 mìle air falbh
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Iuch 2025 · NCT05922878

Sgrùdaidhean Galar Depressive Mòr ann am bailtean eile

Sgrùdaidhean eile ann an Philadelphia

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.